Pentax updates scope reprocessing instructions, EndoChoice receives price target of $19.67 & more – 3 GI company key notes

Here are three recent news updates on key gastroenterology and endoscopy companies.

Advertisement

Pentax Medical updated reprocessing instructions for its ED-3490TK video duodenoscope.

EndoChoice Holdings stock has received an average 12-month consensus price target of $19.67.

Deutsche Bank Securities raised Allergan’s price target to $339.

More articles on GI/endoscopy:
GI physician leader to know: Dr. Shivagi Kothari of University of Rochester Medical Center
EndoChoice receives average price target of $19.67: 4 points
URMC GI experts to host advanced endoscopy course for nurses, mid-level providers: 4 notes

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.